Bhubaneswar, August 22, 2024 — IMGENEX India announces indigenously developed recombinant MPVX proteins, monoclonal and polyclonal antibodies, and Rapid Antigen Test kits for Monkeypox virus detection in collaboration with Samik Diagnostic Pvt. Ltd. (SamikDx).
Read moreIMGENEX India received a 3-year Phase II grant under the BIRAC scheme of the Government of India to develop biosimilar Herceptin (Trastuzumab) for the treatment of breast cancer.
Read moreICMR released the indigenous diagnostic kit to detect common Indian beta-thalassemia mutations, manufactured by IMGENEX India in collaboration with the National Institute of Immunohematology, Mumbai.
Read moreIMGENEX India in collaboration with Indian Agricultural Research Institute, New Delhi was awarded a grant from BIRAC to develop detection kits for plant viruses affecting horticultural crops.
Read more